What is Ilaris?

Ilaris (canakinumab) is a biologic injectable medication used to treat certain inflammatory conditions. It is primarily prescribed for periodic fever syndromes, such as Cryopyrin-Associated Periodic Syndromes (CAPS), Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS), Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD), and Familial Mediterranean Fever (FMF). 

Additionally, Ilaris is used for Still’s disease, which includes Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still’s Disease (AOSD). It works by blocking interleukin-1 beta (IL-1β), a protein involved in inflammation, thereby reducing symptoms associated with these conditions​.